New 'Living Drug' trial targets Tough-to-Treat blood cancer
Disease control
Not yet recruiting
This early-stage trial is testing a new type of treatment called CCTx-001 for adults with acute myeloid leukemia (AML) that has come back or hasn't responded to other therapies. CCTx-001 is a CAR-T cell therapy, which involves modifying a patient's own immune cells to target and …
Phase: PHASE1, PHASE2 • Sponsor: Advesya SAS • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC